Ginkgo Biloba - a drug used to treat diseases of the nervous system.
Release form and composition
The Ginkgo Biloba is produced in the form of hard gelatin capsules, with a red lid and a white body, in blisters of 10 pieces. The capsules are filled with a yellow-brown powder with a specific odor.
Each of them contains 40 or 80 mg of dry extract of ginkgo biloba and excipients - magnesium stearate and lactose monohydrate.
The capsule shell contains gelatin, azorubine (E 122), ponco 4R (E124) and titanium dioxide (E 171).
Indications for use
The instructions for Ginkgo Biloba indicate that the drug is prescribed for the treatment of dyscirculatory encephalopathy, manifested by such symptoms as:
- Peripheral circulation and microcirculation disorders;
- Diabetic retinopathy;
- Sensorineural disorders - ringing in the ears, hypoacuse and dizziness;
- Raynaud's syndrome;
- Senile macular degeneration;
- Sleep disturbances;
- Decreased attention and intellectual abilities;
- Memory loss
The drug is not used in cases of hypersensitivity to the components included in its composition. The drug is not prescribed to children and adolescents under 18 years of age, with acute myocardial infarction, erosive gastritis, hypocoagulation, as well as in the following cases:
- Peptic ulcer and 12 duodenal ulcer;
- Acute disorders of cerebral circulation;
The use of Ginkgo Biloba is contraindicated during pregnancy and during the breastfeeding period.
With caution, the drug should be used for epilepsy, as well as before the planned surgical interventions.
Dosing and Administration
Capsules accept inside entirely, washing down with a glass of water during meal. The dosage of Ginkgo Biloba is determined by the doctor individually. Usually prescribed 40-80 mg (1-2 pieces) means two or three times a day. The duration of drug therapy is three months or more, with the possible repetition of the course after 2-3 months.
In cognitive disorders, patients take 1 capsule (80 mg) 2-3 times a day for 8 weeks or more. In cases of dizziness of involutional and vascular origin, as well as occlusive diseases of the peripheral arteries, 80 mg of Ginkgo Biloba is prescribed 2 times a day for 56 days.
In most cases, the drug is well tolerated by patients. In rare cases, with the use of Ginkgo Biloba, side effects occur with some body systems, namely:
- Nausea, vomiting, and dyspeptic symptoms (digestive system);
- Dizziness and headache (nervous system);
- Rash, redness, itching and swelling (skin and skin).
Due to the fact that Ponso R4 is a part of Ginkgo Biloba, it can cause allergic reactions.
With simultaneous use of the drug with anticoagulants, gastrointestinal hemorrhages may occur.
Symptoms of an overdose of Ginkgo Biloba are impaired consciousness, dyspeptic disorders and headache. In such cases, symptomatic treatment is required.
It is important to prevent the simultaneous use of Ginkgo Biloba with anticoagulants and nonsteroidal anti-inflammatory drugs (acetylsalicylic acid).
The first signs of improvement appear 1 month after the start of treatment.
During the period of drug therapy, patients should be careful when driving vehicles and complex mechanisms.
The drug is synonymous with Bilobil, Ginkoum, Tanakan and Memoplant.
Ginkgo Biloba analogs include Memotropil, Amilonosar, Cortexin, Semax, Idebenone, Minicem, Carnitex, Atsefen, Thiocetam, Vinpotropil, Piracetam, Glycine-Bio Pharmaplant, Telektol and Encephabol.
Terms and conditions of storage
The instructions to the Ginkgo Biloba indicate that the product should be stored in a dry place inaccessible to children, well ventilated and protected from light, at a temperature not exceeding 25 ° C.
The drug is released from pharmacies without a prescription. The shelf life of capsules, subject to all recommendations of the manufacturer, is three years.